The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer. Mar 2010 - Cancer Treat. Rev.; 36(2):1532-1967 [PMID:19954892] [Matera L]
Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells. Jul 2009 - Prostate; 69(12):1097-0045 [PMID:19496055] [Brusa D] [Migliore E] [Garetto S] [Simone M] [Matera L]
Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart. Jan 2008 - Int J Immunopathol Pharmacol; 20(4):0394-6320 [PMID:18179743] [D' Hooghe E] [Buttiglieri S] [Bisignano G] [Brusa D] [Camussi G] [Matera L]
